Abstract
Background The COVID-19 pandemic has revealed gaps in global health systems, especially in the low- and middle-income countries (LMICs). Evidence shows that patients with non-communicable diseases (NCDs) are at higher risk of contracting COVID-19 and suffering direct and indirect health consequences. Considering the future challenges such as environmental disasters and pandemics to the LMICs health systems, digital health interventions (DHI) are well poised to strengthen health care resilience. This study aims to implement and evaluate a comprehensive package of DHIs of integrated COVID-NCD care to manage NCDs in primary care facilities in rural Pakistan.
Methods The study is designed as a pragmatic, parallel two-arm, multi-centre, cluster randomised controlled trial. We will randomise 30 primary care facilities in three districts of Punjab, where basic hypertension and diabetes diagnosis and treatment is provided, with a ratio of 1:1 between intervention and control. In each facility, we will recruit 50 patients who have uncontrolled hypertension. The intervention arm will receive training on an integrated COVID-NCD guideline, and will use a smartphone app-based telemedicine platform where patients can communicate with health providers and peer-supporters, along with a remote training and supervision system. Usual care will be provided in the control arm. Patients will be followed up for 10 months. Our primary indicator is systolic blood pressure measured at 10 months. A process evaluation guided by implementation science frameworks will be conducted to explore implementation questions. A cost-effectiveness evaluation will be conducted to inform future scale up in Pakistan and other LMICs.
Discussion Our study is one of the first randomised controlled trials to evaluate the effectiveness of DHIs to manage NCDs to strengthen health system resilience in LMICs. We will also evaluate the implementation process and cost-effectiveness to inform future scale-up in similar resource constrained settings.
Trial registration ClinicalTrials.gov Identifier - NCT05699369
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05699369
Funding Statement
This study is funded by the Canadian Institutes of Health Research (CIHR, https://cihr-irsc.gc.ca/). XW received this fund (grant number: EG7-179465).The funder had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The trial protocol has obtained ethical approval from the Office of Research Ethics at the University of Toronto (Ref: 42337) and the Institutional Review Board of the Association for Social Development, Pakistan (Ref: IORG0011016 dated 04 March 2022)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
Email addresses of authors Xiaolin Wei, xiaolin.wei{at}utoronto.ca
Nida Khan, nidakhan{at}asd.com.pk
Hammad Durrani, hammad.durrani{at}mail.utoronto.ca
Naila Muzaffar, naila{at}asd.com.pk
John Walley, J.Walley{at}leeds.ac.uk
Kevin Thorpe, kevin.thorpe{at}utoronto.ca
Victoria Haldane, v.haldane{at}mail.utoronto.ca
Erija Ge, erjia.ge{at}utoronto.ca
Shiliang Ge, sarah.ge{at}mail.utoronto.ca
Warren Dodd, wdodd{at}uwaterloo.ca
James Wallace, james.wallace{at}uwaterloo.ca
Garry Aslanyan, aslanyang{at}who.int
Muhammad Amir Khan, ccp{at}asd.com.pk
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
List of abbreviations
- ASD
- Association of Social Development
- DHI
- Digital Health Intervention
- ECHO
- Extension for Community Healthcare Outcomes
- RHC
- Rural Health Centre
- NCD
- Non-Communicable Diseases
- LMICs
- Low-and-Middle-Income Countries
- TMU
- Trial Management Unit
- WDF
- World Diabetes Foundation
- WHO
- World Health Organisation
